Literature DB >> 224755

Subunit and fine structure of the glycoprotein of bovine leukemia virus.

B Dietzschold, O R Kaaden, B Frenzel.   

Abstract

The structure of the glycoprotein of bovine leukemia virus (BLV) was investigated. Analysis of BLV under nonreducing conditions revealed two viral glycoproteins with apparent molecular weights of 162,000 (VGP I) and 85,000 (VGP II). After reduction and alkylation, two glycosylated polypeptide chains of apparent molecular weights of 60,000 (gp 60) and 30,000 (gp 30) could be demonstrated in VGP I and VGP II; VGP I appears to contain two molecules of gp 60 and two molecules of gp 30, and VGP II consists of only one molecule of gp 60 and one molecule of gp 30 linked by disulfide bonds. Comparison of the tryptic peptides of gp 60 and gp 30 provided evidence for the existence of partial sequence relationship between gp 60 and gp 30. The structural similarity of the BLV glycoprotein molecule to immunoglobulins is discussed in regard to the possible function of this protein in the pathogenesis of bovine leukemia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 224755

Source DB:  PubMed          Journal:  Ann Rech Vet        ISSN: 0003-4193


  3 in total

1.  Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins.

Authors:  R Z Mamoun; M Morisson; N Rebeyrotte; B Busetta; D Couez; R Kettmann; M Hospital; B Guillemain
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions.

Authors:  E R Johnston; K Radke
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Mutation of a Single Envelope N-Linked Glycosylation Site Enhances the Pathogenicity of Bovine Leukemia Virus.

Authors:  Alix de Brogniez; Amel Baya Bouzar; Jean-Rock Jacques; Jean-Philippe Cosse; Nicolas Gillet; Isabelle Callebaut; Michal Reichert; Luc Willems
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.